Chinachem Leighton Plaza
9th Floor 29 Leighton Road
Causeway Bay
Hong Kong
852 2155 0823
https://www.regencellbioscience.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 12
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Yat-Gai Au | Founder, Chairman & CEO | N/D | N/D | 1973 |
Ms. Michelle Chan | Financial Controller | N/D | N/D | N/D |
Mr. Wai Hong Chung | COO & Chief Strategy Officer | 245.64k | N/D | 1977 |
Ms. Antonia Assang | Senior Vice President of Project Management | N/D | N/D | N/D |
Mr. Yat-Pui Au | Chief Business Officer | N/D | N/D | 1974 |
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
La calificación ISS Governance QuickScore de Regencell Bioscience Holdings Limited a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.